Surviving Pneumonia

Status Recruiting

Clinical Trial Summary

The study aims to explore risk factors for poor prognosis among patients admitted with community-acquired pneumonia (CAP). During a 5-year study period, all patients (aged ≥ 18 years) admitted with CAP at North Zealand Hospital will be invited for inclusion. Questionnaires, anthropometric measures, laboratory tests, and biomaterials will be collected at admission, daily during admission, at discharge and at follow-up. The main clinical outcomes of the study consist of deaths and development of diabetes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03795662
Study type	Observational
Source	Nordsjaellands Hospital
Contact	Camilla Ryrsø, MSc
Phone	+4548293250
Email	camilla.koch.ryrsoe.01@regionh.dk
Status	Recruiting
Phase
Start date	January 7, 2019
Completion date	December 31, 2038

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05722938` - Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)	Phase 3
Terminated	`NCT04972318` - Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia	N/A
Recruiting	`NCT06065618` - Characteristics of Hospitalized Patients With Community-acquired Pneumonia
Not yet recruiting	`NCT03675178` - Clinical Study of Anerning Particle for the Treatment of Childhood Community-acquired Pneumonia	Phase 4
Not yet recruiting	`NCT04166110` - Antibiotic Therapy In Respiratory Tract Infections	N/A
Completed	`NCT02380352` - Short-course Antimicrobial Therapy for Paediatric Respiratory Infections	Phase 4
Completed	`NCT01671280` - Drug Use Investigation Of Azithromycin IV For Community-Acquired Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)	N/A
Completed	`NCT02555852` - Proton Pump Inhibitors and Risk of Community-acquired Pneumonia	N/A
Recruiting	`NCT00752947` - Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors	Phase 4
Completed	`NCT00140023` - Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia	Phase 3
Recruiting	`NCT04089787` - Shortened Antibiotic Treatment of 5 Days in Community-Acquired Pneumonia	Phase 4
Completed	`NCT05356494` - Postural Drainage and PEP Technique in Community Acquired Pneumonia	N/A
Completed	`NCT05133752` - Oral Nemonoxacin in Treating Elderly Patients With CAP	Phase 4
Not yet recruiting	`NCT06291012` - Stopping Pneumonia Antibiotherapy Regimen Early	Phase 4
Recruiting	`NCT05002192` - A Retrospective, Real-world Study of ELP Used in the Expectorant Treatment of Community-acquired Pneumonia
Completed	`NCT03452826` - Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired Pneumonia	N/A
Terminated	`NCT04071041` - Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.	Phase 3
Completed	`NCT03474991` - KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP	Phase 3
Completed	`NCT01723644` - Clinical Reassessment Versus Procalcitonin in Order to Shorten Antibiotic Duration in Community-acquired Pneumonia	N/A
Completed	`NCT01683487` - Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.	Phase 4